ARCHIVES

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

ACS Study Shows Reduced Mortality For Low T/N Brands

April 18, 1980

Aggressive, Tailored Therapy Improves Survival, Study Finds

October 31, 2008

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

Pitot Named New NCAB Chairman

May 4, 1979

Approval Granted For New Formulation of Lupron Depot

July 29, 2011